Bolzano, February 2, 2026 – Intermedical Pharma has successfully completed the planning phase for the structural and technical measures at its new production site located on Kravoglstraße in Bolzano (former Brasolin Auto area). The facility will be used for the manufacturing of dental anesthetics and represents a key pillar of Intermedical Pharma’s production strategy within the Gallmetzer HealthCare Group.
Construction and refurbishment works on the building are proceeding as planned and are scheduled for completion by mid-March 2026. The scope of work includes both exterior construction and interior fit-out, ensuring that the facility will be fully prepared on time for the subsequent equipment installation and commissioning phases.
Following completion of the construction works, requests for quotations will be initiated, particularly for the equipment of the so-called “white sterile room” – a highly sensitive cleanroom area for sterile manufacturing – as well as the required technical and production systems. This step will mark the next major milestone in the technical implementation of the new production site.
Intermedical Pharma is a specialized manufacturer of dental anesthetics and other dental medical products. As part of the portfolio of Gallmetzer HealthCare S.p.A., an internationally active group in the dental and healthcare sectors, the company benefits from a strong, integrated network encompassing research, development, production and distribution.
In December 2025, Gallmetzer HealthCare S.p.A. successfully completed its listing on the Vienna Stock Exchange, in the Direct Market Plus segment, positioning the group as a growth-oriented company on the capital markets. This milestone creates additional financial and strategic flexibility for investments in production infrastructure, innovation and international expansion.
“With the new production site on Kravoglstraße, we are not only strengthening our regional presence, but also laying the foundation for future-proof and resilient production capacity in the dental sector,” says Dietrich Gallmetzer, CEO. “The project is on schedule and we are well prepared for the upcoming technical and production-related challenges.”
The development of the new site is part of Intermedical Pharma’s strategic growth agenda within the Gallmetzer HealthCare network, which brings nearly 40 years of experience in the dental industry and stands for quality, innovation and sustainability.